BNP but not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Nigro, Nicole ^a   Wildi, Karin ^a   Mueller, Christian ^a   Schuetz, Philipp ^a,b   Mueller, Beat ^a,b   Fluri, Felix ^a   Christ Crain, Mirjam ^a   Katan, Mira ^a,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Medical University Clinic   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I; BIOLOGICAL MARKER;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEATH; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROIMAGING; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY; BLOOD; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; STROKE; TIME;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RECURRENCE; STROKE; TIME FACTORS; TROPONIN I;

EID: 84905046994     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102704     Document Type: Article

References (42)

1. Katan M, Elkind MS (2011) Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke. Expert Rev Neurother 11: 225-239.
2. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU (2001) Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 32: 2735-2740. (Pubitemid 33134456)
3. Davis M, Espiner E, Richards G, Billings J, Town I, et al. (1994) Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 343: 440-444. (Pubitemid 24059585)
4. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, et al. (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161-167. (Pubitemid 34764819)
5. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, et al. (2003) Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42: 728-735. (Pubitemid 37000195)
6. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, et al. (2003) Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol 42: 1793-1800. (Pubitemid 37433660)
7. Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, et al. (2010) Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 121: 200-207.
8. Montaner J, Perea-Gainza M, Delgado P, Ribo M, Chacon P, et al. (2008) Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 39: 2280-2287.
9. Shibazaki K, Kimura K, Iguchi Y, Okada Y, Inoue T (2009) Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med 48: 259-264.
10. Shibazaki K, Kimura K, Iguchi Y, Aoki J, Sakai K, et al. (2011) Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillation. Eur - J Neurol 18: 165-169.
11. Montaner J, Garcia-Berrocoso T, Mendioroz M, Palacios M, Perea-Gainza M, et al. (2012) Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome. Cerebrovasc Dis 34: 240-245.
12. Shibazaki K, Kimura K, Okada Y, Iguchi Y, Uemura J, et al. (2009) Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke. Intern Med 48: 1601-1606.
13. Rost NS, Biffi A, Cloonan L, Chorba J, Kelly P, et al. (2012) Brain natriuretic peptide predicts functional outcome in ischemic stroke. Stroke 43: 441-445.
14. Mortezabeigi HR, Taghizadeh A, Talebi M, Amini K, Goldust M (2013) ABCD2 score and BNP level in patients with TIA and cerebral stroke. Pak J Biol Sci 16: 1393-1397.
15. Garcia-Berrocoso T, Giralt D, Bustamante A, Etgen T, Jensen JK, et al. (2013) B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis. Neurology 81: 1976-1985.
16. Reiter M, Twerenbold R, Reichlin T, Benz B, Haaf P, et al. (2012) Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 33: 988-997.
17. Christensen H, Johannesen HH, Christensen AF, Bendtzen K, Boysen G (2004) Serum cardiac troponin I in acute stroke is related to serum cortisol and TNF-alpha. Cerebrovasc Dis 18: 194-199. (Pubitemid 39279393)
18. Di Angelantonio E, Fiorelli M, Toni D, Sacchetti ML, Lorenzano S, et al. (2005) Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 76: 76-81. (Pubitemid 40013494)
19. Faiz KW, Thommessen B, Einvik G, Brekke PH, Omland T, et al. (2014) Determinants of high sensitivity cardiac troponin T elevation in acute ischemic stroke. BMC Neurol 14: 96.
20. Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, et al. (2009) Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol 66: 799-808.
21. Hatano S (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54: 541-553.
22. Brott T, Adams HP, Jr., Olinger CP, Marler JR, Barsan WG, et al. (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20: 864-870. (Pubitemid 19188240)
23. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, et al. (2007) Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369: 283-292. (Pubitemid 46136488)
24. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41. (Pubitemid 23014379)
25. Tang WH, Wu Y, Nicholls SJ, Brennan DM, Pepoy M, et al. Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation. Arterioscler Thromb Vasc Biol 30: 634-640.
26. Mingels A, Jacobs L, Michielsen E, Swaanenburg J, Wodzig W, et al. (2009) Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 55: 101-108.
27. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, et al. (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361: 858-867.
28. Szabo K, Kern R, Gass A, Hirsch J, Hennerici M (2001) Acute stroke patterns in patients with internal carotid artery disease: a diffusion-weighted magnetic resonance imaging study. Stroke 32: 1323-1329. (Pubitemid 32530417)
29. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845.
30. Pencina MJ, D'Agostino RB, Sr., Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30: 11-21.
31. Konig IR, Ziegler A, Bluhmki E, Hacke W, Bath PM, et al. (2008) Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke 39: 1821-1826.
32. Jimenez Caballero PE, Lopez Espuela F, Portilla Cuenca JC, Ramirez Moreno JM, Pedrera Zamorano JD, et al. (2013) Charlson comorbidity index in ischemic stroke and intracerebral hemorrhage as predictor of mortality and functional outcome after 6 months. J Stroke Cerebrovasc Dis 22: e214-218.
33. Codognotto M, Piccoli A, Zaninotto M, Mion M, Plebani M, et al. (2007) Renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies. Clin Chem 53: 2097-2104. (Pubitemid 350197292)
34. Idris I, Hill R, Ross I, Sharma JC (2010) N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke. Age Ageing 39: 752-755.
35. Etgen T, Baum H, Sander K, Sander D (2005) Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke 36: 270-275. (Pubitemid 40170807)
36. Makikallio AM, Makikallio TH, Korpelainen JT, Vuolteenaho O, Tapanainen JM, et al. (2005) Natriuretic peptides and mortality after stroke. Stroke 36: 1016-1020. (Pubitemid 40629295)
37. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH (2009) Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology 73: 393-399.
38. Katan M, Fluri F, Schuetz P, Morgenthaler NG, Zweifel C, et al. (2010) Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. J Am Coll Cardiol 56: 1045-1053.
39. Jensen JK, Kristensen SR, Bak S, Atar D, Hoilund-Carlsen PF, et al. (2007) Frequency and significance of troponin T elevation in acute ischemic stroke. Am J Cardiol 99: 108-112. (Pubitemid 44969349)
40. Jensen JK, Ueland T, Aukrust P, Antonsen L, Kristensen SR, et al. (2012) Highly sensitive troponin T in patients with acute ischemic stroke. Eur Neurol 68: 287-293.
41. Rizos T, Guntner J, Jenetzky E, Marquardt L, Reichardt C, et al. (2012) Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 43: 2689-2694.
42. Hendrikx T, Hornsten R, Rosenqvist M, Sandstrom H (2013) Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-ofhospital population. BMC Cardiovasc Disord 13: 41.